FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 301:682-686 September 27, 1979 Number 13 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Three biochemical tests for the diagnosis of pheochromocytoma were evaluated in 24 patients with proved tumors and 40 patients whose clinical picture was suspect but who had no evidence of the disease. Measurement of resting, supine plasma catecholamines (by radioenzymatic assay) was more useful than either 24-hour urinary vanillylmandelic acid (VMA) or metanephrines or both. In only one of 23 patients with pheochromocytoma were plasma catecholamines within the range of those in patients without pheochromocytoma, as compared with urinary VMA in 11 of 22, urinary metanephrines in five of 22 and both metabolites in three of 22. These studies reaffirm the value of plasma catecholamines in the diagnosis of pheochromocytoma and indicate that urinary catecholamine metabolites are less useful. The poor correlation between the height of arterial pressure and circulating levels of catecholamines suggests that the regulation of arterial pressure in pheochromocytoma is complex.

This article has been cited by other articles:

• Karagiannis, A., Mikhailidis, D. P, Athyros, V. G, Harsoulis, F. (2007). Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 14: 935-956 [Abstract] [Full Text]  
• Bravo, E. L., Tagle, R. (2003). Pheochromocytoma: State-of-the-Art and Future Prospects. Endocr. Rev. 24: 539-553 [Abstract] [Full Text]  
• Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., Eisenhofer, G. (2002). Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?. JAMA 287: 1427-1434 [Abstract] [Full Text]  
• Grouzmann, E., Fathi, M., Gillet, M., de Torrente, A., Cavadas, C., Brunner, H., Buclin, T. (2001). Disappearance Rate of Catecholamines, Total Metanephrines, and Neuropeptide Y from the Plasma of Patients after Resection of Pheochromocytoma. Clin. Chem. 47: 1075-1082 [Abstract] [Full Text]  
• Sandur, S., Dasgupta, A., Shapiro, J. L., Arroliga, A. C., Mehta, A. C. (1999). Thoracic Involvement With Pheochromocytoma: A Review. Chest 115: 511-521 [Abstract] [Full Text]  
• Eisenhofer, G., Keiser, H., Friberg, P., Mezey, E., Huynh, T.-T., Hiremagalur, B., Ellingson, T., Duddempudi, S., Eijsbouts, A., Lenders, J. W. M. (1998). Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol-O-Methyltransferase Within Tumors. J. Clin. Endocrinol. Metab. 83: 2175-2185 [Abstract] [Full Text]  
• Dawes, M., Chowienczyk, P. J., Ritter, J. M. (1997). Effects of Inhibition of the L-Arginine/Nitric Oxide Pathway on Vasodilation Caused by ß-Adrenergic Agonists in Human Forearm. Circulation 95: 2293-2297 [Abstract] [Full Text]  
• Davis, C. A., Kallen, R. J., Goldberg, A. D. (1981). Refractory Hypertension in an Otherwise Healthy Adolescent. CLIN PEDIATR 20: 587-590 [Abstract]